Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...

Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its ...

Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...

The collaboration supports efforts for HIV prevention through PrEP, emphasizing Hetero’s commitment to improving HIV care.

If approved, the six manufacturers – Dr Reddy’s Laboratories Limited, Emcure, Eva Pharma, Ferozsons Laboratories Limited, ...

It is one of six global partners to have signed a voluntary licence agreement with Gilead to produce a high-quality generic ...

Six drugmakers sign agreements with Gilead Sciences to produce generic lenacapavir, a long-acting HIV drug, amid patent ...

Ferozsons Laboratories Limited (Ferozsons), a Pakistani pharmaceutical, has entered into a non-exclusive voluntary license ...

Gilead Sciences, Inc. has announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six ...

HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV ...

A new licensing agreement from Gilead Sciences and six generic drug manufacturers is poised to transform HIV prevention ...